Top in rheumatology: COVID-19 vaccination in rituximab users; familial Mediterranean fever

Research has shown that breakthrough SARS-CoV-2 infections are common among patients using rituximab. However, a new study found that few rituximab users who are fully vaccinated against COVID-19 develop severe symptoms.
The results “offer assurance to other clinicians who treat their patients with rituximab that this treatment appears to be generally safe in the context of a pandemic, as long as their patients are fully vaccinated,” Md Yuzaiful Md Yusof, PhD, MRCP, of the Leeds Institute of Rheumatic and Musculoskeletal Medicine at the University of Leeds, told Healio. It was the

Research has shown that breakthrough SARS-CoV-2 infections are common among patients using rituximab. However, a new study found that few rituximab users who are fully vaccinated against COVID-19 develop severe symptoms.
The results “offer assurance to other clinicians who treat their patients with rituximab that this treatment appears to be generally safe in the context of a pandemic, as long as their patients are fully vaccinated,” Md Yuzaiful Md Yusof, PhD, MRCP, of the Leeds Institute of Rheumatic and Musculoskeletal Medicine at the University of Leeds, told Healio. It was the